Gaurav Mishra | Intellepedia

Missed filing a request for examination? court says, condonable under exceptional circumstances.

The Madras High Court held that delays in filing a request for examination can be condoned under exceptional circumstances, particularly when caused by agent errors. This case highlights both the strict nature of Indian patent timelines and the judiciary’s role in allowing limited flexibility.

After Natco, Bajaj Healthcare files compulsory license against Eli Lilly; EPO Enlarged Board of Appeal issues decision on ‘double patenting’ and more

Bajaj Healthcare has applied for a compulsory license against Eli Lilly for Baricitinib, citing affordability concerns. The post also covers the EPO’s decision on double patenting, updates from the IP5 meeting on AI patents, and new initiatives by WHO, WTO, and WIPO.

Free Masterclass on IP; Nokia and Daimler settle SEP patent dispute; EU submits alternative proposal to WTO against IP waiver and more

This week’s patent news features a free masterclass on patent filing, Nokia and Daimler’s settlement of a SEP dispute, and the EU’s alternative proposal to the WTO on IP waivers. Also covered are updates on the USPTO’s move to structured text filing for patent applications.

Drastic decrease in patent publications and grants this week

This week’s Indian patent statistics reveal a notable decline in patent publications and grants compared to the previous week. The report offers a comprehensive breakdown by city and category, compiled by BananaIP Counsels.

Natco withdraws compulsory license, signs agreement with Eli Lilly for Barcitinib; Patent Office notifies extension of timelines and more

Natco Pharma has withdrawn its compulsory license application for Baricitinib following an agreement with Eli Lilly. The Indian Patent Office has extended procedural deadlines, and other significant updates in IP law are discussed, including ongoing litigation and international proposals.

Natco files compulsory license request; USA approves temporary patent waiver; Ericsson and Samsung settle dispute and more

Natco seeks a compulsory license for Baricitinib, while the USA backs a temporary COVID-19 vaccine patent waiver. The EU critiques the US approach, and Ericsson and Samsung resolve their ongoing patent dispute. WIPO also releases a new guide on industrial design registration.

Supreme Court restores order extending time limits indefinitely, asks why Government is not invoking compulsory licensing provisions and more

The Supreme Court has indefinitely extended limitation periods for legal proceedings in view of the COVID-19 situation and questioned the Government’s approach to compulsory licensing of essential medicines. India also features on the US Special 301 Report’s Priority Watch List, while the USPTO is hosting free design patent webinars.

Delhi High Court asks government to consider issuing compulsory licenses, World IP day 2021, a solemn affair this year, India – South Africa patent waiver proposal opposed again and more

The Delhi High Court has advised the government to consider compulsory licensing of COVID-19 treatments, reflecting the urgent need for wider access. This post also covers the global debate on patent waivers and the observance of World IP Day 2021, with a focus on recent legal and policy updates.

Nokia and Lenovo settle patent dispute, Apple wins $506 Million patent-damages appeal and more

This post provides an analytical overview of recent patent disputes and policy developments. It discusses the Nokia-Lenovo settlement, Apple’s patent damages appeal, and new USPTO initiatives related to COVID-19, offering a legal perspective on each event.

President promulgates Tribunals reforms Ordinance, IPAB goes defunct with immediate effect

The Tribunals Reforms Ordinance 2021 has made the IPAB and several other tribunals defunct, transferring their powers to the High Courts and Commercial Courts. This post provides a brief overview of the key statutory amendments affecting intellectual property laws in India.